EMILY LANGLINAIS: Open Payments
NPI 1134845662 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,390 in 66 payments from 18 companies in 2025. Trend: 2023 $1,468 · 2024 $1,501 · 2025 $1,390
Food & beverage: $1,210Education: $180
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $357 |
| Janssen Biotech, Inc. | 6 | $246 |
| UCB, Inc. | 9 | $151 |
| GENZYME CORPORATION | 7 | $139 |
| Lilly USA, LLC | 4 | $93 |
| LEO Pharma Inc. | 3 | $85 |
| Incyte Corporation | 3 | $55 |
| Almirall LLC | 2 | $40 |
| Botanix SB Inc | 2 | $36 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $30 |
Products named: TREMFYA, SKYRIZI, RINVOQ, DUPIXENT, Bimzelx, TALTZ, OPZELURA, ADBRY.
Industry payments across LA — which companies pay providers there.
